These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 710514)

  • 21. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M
    Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract]   [Full Text] [Related]  

  • 22. Solubilization and characterization of [3H]spiroperidol binding sites from subcellular fractions of the calf striatum.
    Clement-Cormier YC; Kendrick PE
    Biochem Pharmacol; 1980 Mar; 29(6):897-903. PubMed ID: 7387707
    [No Abstract]   [Full Text] [Related]  

  • 23. 3H-Spiroperidol labels dopamine receptors in pituitary and brain.
    Creese I; Schneider R; Snyder SH
    Eur J Pharmacol; 1977 Dec; 46(4):377-81. PubMed ID: 590345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN.
    Buczko W; De Blasi A
    Pol J Pharmacol Pharm; 1983; 35(1):45-7. PubMed ID: 6889186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of typical and atypical neuroleptics on binding of [3H]spiroperidol in calf caudate.
    Lin CW; Maayani S; Wilk S
    J Pharmacol Exp Ther; 1980 Mar; 212(3):462-8. PubMed ID: 6102144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
    Lai HC; Carino MA; Horita A
    Proc West Pharmacol Soc; 1981; 24():5-6. PubMed ID: 6114496
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic treatment with metoclopramide induces behavioral supersensitivity to apomorphine and enhances specific binding of 3H-spiroperidol to rat striata.
    Lautin A; Wazer D; Stanley M; Rotorsen J; Gershon S
    Life Sci; 1980 Jul; 27(4):305-16. PubMed ID: 7412477
    [No Abstract]   [Full Text] [Related]  

  • 28. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD; Jenner P; Kelly E; Marsden CD
    Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and partial purification of a hydrophobic protein component associated with [3H]spiroperidol-binding activity.
    Boyan-Salyers BD; Clement-Cormier Y
    Biochim Biophys Acta; 1980 Feb; 617(2):274-81. PubMed ID: 7357020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine receptors in bovine retina : characterization of the 3H-spiroperidol binding and its use for screening dopamine receptor affinity of drugs.
    Magistretti PJ; Schorderet M
    Life Sci; 1979 Nov; 25(19):1675-86. PubMed ID: 41997
    [No Abstract]   [Full Text] [Related]  

  • 32. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cations and temperature on the binding of [3H]spiperone to sheep caudate nucleus.
    Oliveira CR; Wajda I; Lajtha A; Carvalho AP
    Biochem Pharmacol; 1983 Feb; 32(3):417-22. PubMed ID: 6847696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for in vivo binding of apomorphine and bromocriptine to receptor sites not labelled by 3H-spiperone.
    Köhler C; Fuxe K; Ogren SO; Agnati L
    Eur J Pharmacol; 1979 Oct; 58(3):339-40. PubMed ID: 510366
    [No Abstract]   [Full Text] [Related]  

  • 37. Two binding sites for 3H-spiroperidol on rat striatal membranes.
    Briley M; Langer SZ
    Eur J Pharmacol; 1978 Aug; 50(3):283-4. PubMed ID: 28956
    [No Abstract]   [Full Text] [Related]  

  • 38. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cations decrease specific [3H]-spiroperidol binding in human prefrontal cortex.
    Huang EH; Pickett JM; Siegal JD; Andorn AC
    Life Sci; 1986 Apr; 38(15):1369-73. PubMed ID: 3959758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic and dopamine receptors: autoradiographic localization of [3H]spiperone in rat brain.
    Klemm N; Murrin LC; Kuhar MJ
    Brain Res; 1979 Jun; 169(1):1-9. PubMed ID: 455088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.